Wacker to Consolidate Pyrogenic Silica Production

Wacker Chemie AG announced today that it is consolidating pyrogenic silica production in the context of previously announced structural improvement measures at its WACKER SILICONES division. As a result, WACKER plans to close its Kempten site during 2011. The Munich-based chemical company intends to transfer Kempten's production volumes to Burghausen and Nünchritz, optimizing capacity utilization at these sites' high-volume facilities.

The planned closure has led to impair-ments on fixed assets of some €3.5 million and to a €5.5 million provision. WACKER has recognized both amounts in its consolidated financial statements for 2009. Currently, WACKER has about 50 employees at Kempten.

"Our goal is to close Kempten without layoffs - and I see a very good chance we'll succeed," said WACKER's Personnel Director Dr. Wilhelm Sittenthaler. Measures include offering employees jobs at Burghausen and Nünchritz. "We'll need additional people there in coming years, especially due to the expansion of our polysilicon business. And we will, of course, primarily consider our existing staff for these jobs," stressed Sittenthaler. As a result, he said he was confident that the closure could be implemented in a socially-acceptable manner via natural fluctuation, phased early retirement and severance packages.

WACKER is the world's third-largest producer of pyrogenic silica, which it markets as HDK. This high-purity, amorphous silicon dioxide powder is used as a filler in silicone elastomers and as a viscosity-adjusting agent in coatings, printing inks, adhesives, unsaturated polyester resins and plastisols. It also serves as a flow aid in the cosmetics, pharmaceutical and food industries.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.